REVIVE Logo REVIVE Logo REVIVE Logo
GARDP Forums Retina Logo
  • About
  • The Experts
  • Webinars & Conferences
    • Webinars
    • Conferences
    • External Webinars
  • Blog
  • Resources
  • Forums
  • Talk to an expert
  • JOIN US
    • Log in
    • Lost your password?
    • Create your account
  • My account
    • Logout
Loading...

  • Webinars

You are here:Home-Webinars
PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?
more

PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?

26 June 2018
<br>Antibacterial drugs: Clinical development for non-developers </br> Part 1: Traditional development – tiers A and B
more

Antibacterial drugs: Clinical development for non-developers Part 1: Traditional development – tiers A and B

13 June 2018
  • « Previous
  • 1
  • 2

Share

FacebookTwitterLinkedInRedditEmail

REVIVE

REVIVE is a space for everybody with an interest in antimicrobial R&D.

The Global Antibiotic Research & Development Partnership (GARDP) aims to develop and deliver new treatments for bacterial infections where drug resistance is present or emerging, or for which inadequate treatment exists, while endeavouring to ensure sustainable access.

Popular forum topics

  • Superiority vs. non-inferiority studies – can PK-PD bridge this gap?
  • Setting Up A 'Support' Service in Anti-Infectives
  • Immunomodulators
  • Plant extracts for pan-drug resistant bugs?

Latest forum posts

  • Medicare’s New Technology Add-on Payment (NTAP) program
  • Lung or thigh infection models for UTI/ABSSI indication
  • Route of administration for treatment vs. that for determining PK
  • MIC50 or MIC90 in PD calculations?

CONNECT

  • Twitter
  • LinkedIn
  • YouTube

  • GARDP
  • DNDi
© All Rights Reserved
Privacy Policy | Terms of Use | Acceptable Use Policy | Cookie Policy
We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser.
Read our cookie policy